OFS
OTLK icon

Orrstown Financial Services’s Outlook Therapeutics OTLK Stock Holding History

Orrstown Financial Services’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.9K Buy
+15,000
New +$9.3K ﹤0.01% 118

Other funds holding OTLK

CKAIS
Christensen King & Associates Investment Services Richland, Washington $252M AUM 20.51% 1-Year Est. Return
FCC
Flower City Capital Pittsford, New York $227M AUM 23.31% 1-Year Est. Return
FTWA
Fifth Third Wealth Advisors Cincinnati, Ohio $3.58B AUM 34.55% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return

Orrstown Financial Services's OTLK Position: Q2 2026 in Review

Orrstown Financial Services opened a new position in Outlook Therapeutics (OTLK) in Q2 2026: 15,000 shares worth $23.9K. The stake represents ﹤0.01% of the portfolio and ranks #118 among its holdings.

6 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

  • Orrstown Financial Services held 15,000 shares of Outlook Therapeutics worth $23.9K as of Q2 2026.
  • Outlook Therapeutics was a new Orrstown Financial Services position in Q2 2026.
  • Outlook Therapeutics made up ﹤0.01% of Orrstown Financial Services's portfolio in Q2 2026, its #118 holding.
  • 6 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on Orrstown Financial Services's 13F filing for Q2 2026, filed 10 Jul 2026.